BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22799383)

  • 1. Efficacy of Pap test in combination with ThinPrep cytological test in screening for cervical cancer.
    Chen H; Shu HM; Chang ZL; Wang ZF; Yao HH; Zhu HM; Lu TM; Ma QY; Yang BL
    Asian Pac J Cancer Prev; 2012; 13(4):1651-5. PubMed ID: 22799383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
    Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
    Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
    Pan Q; Belinson JL; Li L; Pretorius RG; Qiao YL; Zhang WH; Zhang X; Wu LY; Rong SD; Sun YT
    Acta Cytol; 2003; 47(1):45-50. PubMed ID: 12585030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of TruScreen in detecting ASCUS patients.
    Li W; Guo Y; Niu H; Jin S; Wang L
    Asian Pac J Trop Med; 2011 Aug; 4(8):669-71. PubMed ID: 21914550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on cervix biopsy guided by colposcopy in diagnosis of cervical diseases in pregnant women].
    Wang T; Wu YM; Song F; Zhu L; Li BZ; Hao X; Kong WM; Duan W; Fan L; Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):497-500. PubMed ID: 21029600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
    Mannino JR
    J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
    Lee NW; Kim D; Park JT; Kim A
    Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
    Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
    Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical results of a split sample liquid-based cytology (ThinPrep) study of 4,322 patients in a Turkish institution.
    Tuncer ZS; Başaran M; Sezgin Y; Firat P; Mocan Kuzey G
    Eur J Gynaecol Oncol; 2005; 26(6):646-8. PubMed ID: 16398228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between visual inspection of cervix and cytology based screening procedures in Bangladesh.
    Nessa A; Nahar KN; Begum SA; Anwary SA; Hossain F; Nahar K
    Asian Pac J Cancer Prev; 2013; 14(12):7607-11. PubMed ID: 24460341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk Communities.
    Tao L; Amanguli A; Li F; Wang YH; Yang L; Mohemaiti M; Zhao J; Zou XG; Saimaiti A; Abudu M; Maimaiti M; Chen SY; Abudukelimu R; Maimaiti A; Li SG; Zhang W; Aizimu A; Yang AQ; Wang J; Pang LJ; Cao YG; Gu WY; Zhang WJ
    Obstet Gynecol; 2018 Dec; 132(6):1421-1429. PubMed ID: 30399093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.